Life Science REIT (LON:LABS) Shares Down 0.5% – Should You Sell?

Life Science REIT plc (LON:LABS) dropped 0.5% during mid-day trading on Tuesday . The company traded as low as GBX 36.70 ($0.45) and last traded at GBX 36.70 ($0.45). Approximately 321,672 shares traded hands during trading, a decline of 21% from the average daily volume of 409,043 shares. The stock had previously closed at GBX 36.90 ($0.46).

Analysts Set New Price Targets

Several equities research analysts have weighed in on the stock. Berenberg Bank reiterated a “buy” rating and issued a GBX 57 ($0.70) target price on shares of Life Science REIT in a report on Thursday, October 3rd. Shore Capital restated a “buy” rating on shares of Life Science REIT in a report on Thursday, September 26th.

Life Science REIT Trading Down 1.1 %

The stock’s 50 day moving average is GBX 39.06 and its two-hundred day moving average is GBX 36.61. The stock has a market capitalization of £122.15 million, a price-to-earnings ratio of -581.67 and a beta of 0.08.

Life Science REIT Company Profile

Life Science REIT plc (the Company) is a closed-ended Real Estate Investment Trust (REIT) incorporated in England and Wales on 27 July 2021. The Company began trading on 19 November 2021 and its shares are admitted to trading on the Premium Listing Segment of the Main Market of the London Stock Exchange.